BRPI0813787A2 - Cultura de célula-tronco pluripotente isolada - Google Patents

Cultura de célula-tronco pluripotente isolada

Info

Publication number
BRPI0813787A2
BRPI0813787A2 BRPI0813787-0A2A BRPI0813787A BRPI0813787A2 BR PI0813787 A2 BRPI0813787 A2 BR PI0813787A2 BR PI0813787 A BRPI0813787 A BR PI0813787A BR PI0813787 A2 BRPI0813787 A2 BR PI0813787A2
Authority
BR
Brazil
Prior art keywords
cell culture
stem cell
pluripotent stem
isolated pluripotent
isolated
Prior art date
Application number
BRPI0813787-0A2A
Other languages
English (en)
Inventor
Shelley Nelson
Original Assignee
Lifescan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lifescan Inc filed Critical Lifescan Inc
Publication of BRPI0813787A2 publication Critical patent/BRPI0813787A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0606—Pluripotent embryonic cells, e.g. embryonic stem cells [ES]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0676—Pancreatic cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2509/00—Methods for the dissociation of cells, e.g. specific use of enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/90—Substrates of biological origin, e.g. extracellular matrix, decellularised tissue

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
BRPI0813787-0A2A 2007-07-01 2008-06-30 Cultura de célula-tronco pluripotente isolada BRPI0813787A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US94744407P 2007-07-01 2007-07-01
PCT/US2008/068782 WO2009006399A1 (en) 2007-07-01 2008-06-30 Single pluripotent stem cell culture

Publications (1)

Publication Number Publication Date
BRPI0813787A2 true BRPI0813787A2 (pt) 2014-10-07

Family

ID=39733580

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0813787-0A2A BRPI0813787A2 (pt) 2007-07-01 2008-06-30 Cultura de célula-tronco pluripotente isolada

Country Status (13)

Country Link
EP (3) EP2559756B1 (pt)
JP (1) JP2010532172A (pt)
KR (3) KR20160054032A (pt)
CN (2) CN101978044B (pt)
BR (1) BRPI0813787A2 (pt)
CA (1) CA2691975C (pt)
DK (1) DK3192865T3 (pt)
ES (1) ES2626656T3 (pt)
MX (1) MX2010000348A (pt)
PL (1) PL2173862T3 (pt)
RU (1) RU2473687C2 (pt)
WO (1) WO2009006399A1 (pt)
ZA (1) ZA201000715B (pt)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8895300B2 (en) 2008-11-04 2014-11-25 Viacyte, Inc. Scalable primate pluripotent stem cell aggregate suspension culture and differentiation thereof
PH12012501686A1 (en) 2010-03-01 2020-10-19 Janssen Biotech Inc Methods for purifying cells derived from pluripotent stem cells
BR112013017629A2 (pt) 2010-12-17 2017-04-18 Biolamina Ab laminina-521 recombinante
PL2718416T3 (pl) * 2011-06-06 2020-05-18 ReGenesys BVBA Namnażanie komórek macierzystych w bioreaktorach włóknisto-kapilarnych
CA2849244C (en) 2011-09-22 2023-10-10 Karl Tryggvason Cell culture substrate comprising a laminin and a cadherin
FI2794857T3 (fi) 2011-12-22 2026-03-25 Janssen Biotech Inc Ihmisen alkion kantasolujen erilaistaminen yksittäisiksi hormonaalisiksi insuliinipositiivisiksi soluiksi
BR112014027783A2 (pt) * 2012-05-07 2017-06-27 Janssen Biotech Inc diferenciação de células-tronco embrionárias humanas em endoderma pancreático
CN104903440B (zh) 2012-09-03 2018-04-06 诺和诺德股份有限公司 使用小分子从多能干细胞产生胰内胚层
US10370644B2 (en) 2012-12-31 2019-08-06 Janssen Biotech, Inc. Method for making human pluripotent suspension cultures and cells derived therefrom
ES2837763T3 (es) 2012-12-31 2021-07-01 Janssen Biotech Inc Cultivo de células madre embrionarias humanas en la interconexión aire-líquido para la diferenciación en células endocrinas pancreáticas
BR112015015714A2 (pt) 2012-12-31 2017-07-11 Janssen Biotech Inc suspensão e aglomeração de células pluripotentes humanas para diferenciação em célu-las endócrinas pancreáticas
WO2015065524A2 (en) * 2013-11-01 2015-05-07 Janssen Biotech, Inc. Suspension and clustering of human pluripotent stem cells for differentiation into pancreatic endocrine cells
RU2553332C1 (ru) * 2014-08-05 2015-06-10 Дмитрий Андреевич Журавлёв Система культивирования плюрипотентных стволовых клеток
RU2614260C1 (ru) * 2016-01-28 2017-03-24 Общество с ограниченной ответственностью фирмы "Имтек" Двухслойная, плоская, прозрачная подложка гидрогеля для длительного культивирования клеток
CN107841481A (zh) * 2016-09-19 2018-03-27 深圳华大方舟生物技术有限公司 一种用于单细胞培养的培养基及其制备方法和应用
WO2018218105A1 (en) * 2017-05-26 2018-11-29 Kite Pharma, Inc. Methods of making and using embryonic mesenchymal progenitor cells
EP3676612A4 (en) * 2017-08-31 2021-05-26 Agilent Technologies, Inc. COMPOSITION FOR THE STABILIZATION OF ANTIBODY FORMULATIONS CONTAINING PERCP
CA3139292C (en) 2019-05-31 2025-06-10 Viacyte, Inc. CELL ENCAPSULATION DEVICES WITH REGULATED OXYGEN DIFFUSION DISTANCES
EP3976236A1 (en) 2019-05-31 2022-04-06 W.L. Gore & Associates Inc. A biocompatible membrane composite
CN114173837A (zh) 2019-05-31 2022-03-11 W.L.戈尔及同仁股份有限公司 生物相容性膜复合材料
EP3975926A1 (en) 2019-05-31 2022-04-06 W.L. Gore & Associates, Inc. A biocompatible membrane composite

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4557264A (en) 1984-04-09 1985-12-10 Ethicon Inc. Surgical filament from polypropylene blended with polyethylene
US5863531A (en) 1986-04-18 1999-01-26 Advanced Tissue Sciences, Inc. In vitro preparation of tubular tissue structures by stromal cell culture on a three-dimensional framework
US5567612A (en) 1986-11-20 1996-10-22 Massachusetts Institute Of Technology Genitourinary cell-matrix structure for implantation into a human and a method of making
CA1340581C (en) 1986-11-20 1999-06-08 Joseph P. Vacanti Chimeric neomorphogenesis of organs by controlled cellular implantation using artificial matrices
US5804178A (en) 1986-11-20 1998-09-08 Massachusetts Institute Of Technology Implantation of cell-matrix structure adjacent mesentery, omentum or peritoneum tissue
GB9206861D0 (en) 1992-03-28 1992-05-13 Univ Manchester Wound healing and treatment of fibrotic disorders
US5843780A (en) 1995-01-20 1998-12-01 Wisconsin Alumni Research Foundation Primate embryonic stem cells
CA2307807C (en) 1997-10-23 2008-09-02 Andrea G. Bodnar Methods and materials for the growth of primate-derived primordial stem cells in feeder-free culture
US6372779B1 (en) 1997-12-29 2002-04-16 Ortho Pharmaceutical Corporation Anti-inflammatory compounds
US6667176B1 (en) 2000-01-11 2003-12-23 Geron Corporation cDNA libraries reflecting gene expression during growth and differentiation of human pluripotent stem cells
US6413556B1 (en) 1999-01-08 2002-07-02 Sky High, Llc Aqueous anti-apoptotic compositions
ATE378398T1 (de) * 1999-02-11 2007-11-15 Hanmi Pharm Ind Co Ltd Pluripotente embryonale keimzellinie aus vögeln
US6306424B1 (en) 1999-06-30 2001-10-23 Ethicon, Inc. Foam composite for the repair or regeneration of tissue
US6333029B1 (en) 1999-06-30 2001-12-25 Ethicon, Inc. Porous tissue scaffoldings for the repair of regeneration of tissue
US7439064B2 (en) 2000-03-09 2008-10-21 Wicell Research Institute, Inc. Cultivation of human embryonic stem cells in the absence of feeder cells or without conditioned medium
US7005252B1 (en) 2000-03-09 2006-02-28 Wisconsin Alumni Research Foundation Serum free cultivation of primate embryonic stem cells
US6458589B1 (en) * 2000-04-27 2002-10-01 Geron Corporation Hepatocyte lineage cells derived from pluripotent stem cells
CN100525768C (zh) 2000-10-23 2009-08-12 史密丝克莱恩比彻姆公司 新化合物
US6599323B2 (en) 2000-12-21 2003-07-29 Ethicon, Inc. Reinforced tissue implants and methods of manufacture and use
US6656488B2 (en) 2001-04-11 2003-12-02 Ethicon Endo-Surgery, Inc. Bioabsorbable bag containing bioabsorbable materials of different bioabsorption rates for tissue engineering
US6626950B2 (en) 2001-06-28 2003-09-30 Ethicon, Inc. Composite scaffold with post anchor for the repair and regeneration of tissue
GB0117583D0 (en) 2001-07-19 2001-09-12 Astrazeneca Ab Novel compounds
US20040062753A1 (en) 2002-09-27 2004-04-01 Alireza Rezania Composite scaffolds seeded with mammalian cells
US7144999B2 (en) 2002-11-23 2006-12-05 Isis Pharmaceuticals, Inc. Modulation of hypoxia-inducible factor 1 alpha expression
US20060194315A1 (en) * 2003-03-31 2006-08-31 Condie Brian G Compositions and methods for the control, differentiaton and/or manipulation of pluripotent cells through a gamma-secretase signaling pathway
ITRM20030395A1 (it) 2003-08-12 2005-02-13 Istituto Naz Per Le Malattie Infettive Lazz Terreno di coltura per il mantenimento, la proliferazione e il differenziamento di cellule di mammifero.
WO2005065354A2 (en) 2003-12-31 2005-07-21 The Burnham Institute Defined media for pluripotent stem cell culture
TWI334443B (en) 2003-12-31 2010-12-11 Ind Tech Res Inst Method of single cell culture of undifferentiated human embryonic stem cells
JP2007528226A (ja) 2004-03-10 2007-10-11 リージェンツ オブ ザ ユニヴァーシティ オブ カリフォルニア 胚幹細胞の増殖用組成物および方法
US8187878B2 (en) * 2004-08-13 2012-05-29 University Of Georgia Research Foundation, Inc. Methods for increasing definitive endoderm differentiation of pluripotent human embryonic stem cells with PI-3 kinase inhibitors
GB2444686B (en) 2005-09-12 2010-08-25 Es Cell Int Pte Ltd Differentiation of pluripotent stem cells using p38 MAPK inhibitors or prostaglandins
SG170021A1 (en) * 2006-02-23 2011-04-29 Novocell Inc Compositions and methods useful for culturing differentiable cells
US7964402B2 (en) * 2006-05-25 2011-06-21 Sanford-Burnham Medical Research Institute Methods for culture and production of single cell populations of human embryonic stem cells
US20080003676A1 (en) * 2006-06-26 2008-01-03 Millipore Corporation Growth of embryonic stem cells

Also Published As

Publication number Publication date
CA2691975C (en) 2018-05-01
MX2010000348A (es) 2010-04-12
EP3192865B1 (en) 2021-04-21
CN104250632B (zh) 2018-09-11
CN101978044B (zh) 2017-10-24
KR20160054032A (ko) 2016-05-13
KR20170116172A (ko) 2017-10-18
KR101732952B1 (ko) 2017-05-08
RU2010103046A (ru) 2011-08-10
EP2173862B1 (en) 2017-04-19
CA2691975A1 (en) 2009-01-08
PL2173862T3 (pl) 2017-09-29
KR20100040305A (ko) 2010-04-19
ZA201000715B (en) 2011-04-28
WO2009006399A9 (en) 2016-05-19
EP2559756A1 (en) 2013-02-20
JP2010532172A (ja) 2010-10-07
EP3192865A1 (en) 2017-07-19
CN101978044A (zh) 2011-02-16
EP2173862A1 (en) 2010-04-14
WO2009006399A1 (en) 2009-01-08
ES2626656T3 (es) 2017-07-25
CN104250632A (zh) 2014-12-31
EP2559756B1 (en) 2019-12-18
DK3192865T3 (da) 2021-06-28
RU2473687C2 (ru) 2013-01-27

Similar Documents

Publication Publication Date Title
BRPI0813787A2 (pt) Cultura de célula-tronco pluripotente isolada
GB2458863B (en) Improved culture of stem cells
PL2046946T3 (pl) Hodowla pluripotencjalnych komórek macierzystych
EP2370445A4 (en) STEM CELL CULTURES
ZA201606403B (en) Pluripotent stem cell culture on micro-carriers
DK2574677T3 (da) Fremgangsmåder til celledyrkning
EP2315829A4 (en) INDUCED PLURIPOTENTIAL STEM CELLS
FI20096288A0 (fi) Formulations and methods for culturing stem cells
PL2634242T3 (pl) Ulepszony sposób hodowli komórek
EP2142641A4 (en) UNDIFFERENCED STEM CELL CULTURAL SYSTEMS
EP2414510A4 (en) INDUCED PLURIPOTENTIAL STEM CELLS
EP2456861A4 (en) PRENATAL MESENCHYMAL STEM CELLS
IL216902B (en) Methods for culturing stem and progentitor cells
DK3450545T3 (da) Pluripotente stamceller opnået ved ikke-viral omprogrammering
SG10201500674YA (en) Pluripotent stem cells
EP2331675A4 (en) MARKERS FOR INDUCED PLURIPOTENTIAL STEM CELLS
BRPI0913925A2 (pt) Diferenciação de células-tronco pluripotentes
GB0814249D0 (en) Uses of mesenchymal stem cells
GB0810260D0 (en) Automated culture of stem cells
EP2271739A4 (en) PRODUCT FOR CELL CULTURE
EP2294182A4 (en) CULTS OF MULTIPOTENT STEM CELLS
EP2331676A4 (en) GROWTH FACTOR OF A HEMATOPOIETIC STEM CELL
FI20085724A0 (fi) Soluviljely
AU2014201623B2 (en) Pluripotent stem cell culture
IL201166A0 (en) Undifferentiated stem cell culture systems

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]
B06T Formal requirements before examination [chapter 6.20 patent gazette]
B08F Application fees: application dismissed [chapter 8.6 patent gazette]

Free format text: REFERENTE A 12A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2594 DE 24-09-2020 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.